Makan Delrahim

Makan Delrahim is Adjunct Lecturer in Law at the University of Pennsylvania and former Assistant Attorney General for the Antitrust Division, United States Department of Justice.  Mr. Delrahim previously served as Deputy Assistant to the President and Deputy White House Counsel.  Mr. Delrahim’s rich antitrust background covers the full range of industries, issues, and institutions touched upon by the work of the Antitrust Division.  He is a former partner in the Los Angeles office of a national law firm.  He served in the Antitrust Division from 2003 to 2005 as a Deputy Assistant Attorney General, overseeing the Appellate, Foreign Commerce, and Legal Policy sections.  During that time, he played an integral role in building the Antitrust Division’s engagement with its international counterparts and was involved in civil and criminal matters.  He has served on the Attorney General’s Task Force on Intellectual Property and as Chairman of the Merger Working Group of the International Competition Network.  Mr. Delrahim was also as a Commissioner on the Antitrust Modernization Commission from 2004 to 2007.  Earlier in his career, Mr. Delrahim served as antitrust counsel, and later as the Staff Director and Chief Counsel of the U.S. Senate Judiciary Committee.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More